Image Source - unsplash

Tonix Pharmaceuticals Stock Forecast 2023 to 2030

Image Source - unsplash

Tonix Pharmaceutical Holding Corporation is a popular clinical-stage biopharmaceutical firm.

Image Source - unsplash

The company focuses on making discoveries, developing/ acquiring small molecule licensing...

Image Source - unsplash

Helping to treat and prevent human diseases, and even lowering their suffering.

Image Source - unsplash

Tonix Pharmaceutical’s portfolio comprises central nervous system immunology and other infectious disease product candidates.

Image Source - unsplash

The immunology Tonix Pharmaceutical portfolio comprises biology for addressing autoimmune disease and organ transplant rejection.

Image Source - unsplash

The central nervous system of Tonix Pharmaceutical’s portfolio comprises biologics

Image Source - unsplash